Literature DB >> 27087598

Systems Pharmacology: A Unified Framework for Prediction of Drug-Target Interactions.

Duc-Hau Le1, Ly Le.   

Abstract

BACKGROUND: Drug discovery is one important issue in medicine and pharmacology area. Traditional methods using target-based approach are usually time-consuming and ineffective. Recently, the problems are approached in a system-level view and therefore it is called systems pharmacology. This research field deals with the problems in drug discovery by integrating various kinds of biomedical and pharmacological data and using advanced computational methods. Ultimately, the problems are more effectively solved. One of the most important problem in systems pharmacology is prediction of drug-target interactions.
METHODS: In this review, we are going to summarize various computational methods for this problem.
RESULTS: More importantly, we formed a unified framework for the problem. In addition, to study human health and disease in a more systematically and effectively, we also presented an integrated scheme for a wider problem of prediction of disease-gene-drug associations.
CONCLUSION: By presenting the unified framework and the integrated scheme, underlying computational methods for problems in systems pharmacology can be understood and complex relationships among diseases, genes and drugs can be identified effectively.

Entities:  

Mesh:

Year:  2016        PMID: 27087598     DOI: 10.2174/1381612822666160418121534

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  3 in total

1.  Tianfoshen oral liquid: a CFDA approved clinical traditional Chinese medicine, normalizes major cellular pathways disordered during colorectal carcinogenesis.

Authors:  Siliang Wang; Hengbin Wang; Yin Lu
Journal:  Oncotarget       Date:  2017-02-28

2.  Systems pharmacology-based exploration reveals mechanisms of anti-steatotic effects of Jiang Zhi Granule on non-alcoholic fatty liver disease.

Authors:  Yiyuan Zheng; Miao Wang; Peiyong Zheng; Xudong Tang; Guang Ji
Journal:  Sci Rep       Date:  2018-09-12       Impact factor: 4.379

3.  Gentiana scabra Restrains Hepatic Pro-Inflammatory Macrophages to Ameliorate Non-Alcoholic Fatty Liver Disease.

Authors:  Yiyuan Zheng; Dan Fang; Chaoyuan Huang; Lina Zhao; Liming Gan; Youlan Chen; Fengbin Liu
Journal:  Front Pharmacol       Date:  2022-01-18       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.